Why managed care should provide supportive therapies for cancer patients.
作者信息
Rubenstein S A
机构信息
Group Health Cooperative of Puget Sound, Seattle, USA.
出版信息
Manag Care. 1995 Aug;4(8):37-9.
PMID:10145013
Abstract
摘要
相似文献
1
Why managed care should provide supportive therapies for cancer patients.为什么管理式医疗应该为癌症患者提供支持性治疗。
Manag Care. 1995 Aug;4(8):37-9.
2
Use and coverage of novel cancer agents in managed care.新型癌症药物在管理式医疗中的使用与覆盖情况。
Semin Oncol. 1994 Dec;21(6 Suppl 14):34-7.
3
Managing oncology costs.管理肿瘤治疗成本。
Am J Manag Care. 2006 Feb;12(1 Suppl):S3-16; quiz S17-9.
4
[Cytostatic therapy in cancer--a SBU report].[癌症的细胞抑制疗法——一份瑞典卫生技术评估委员会报告]
Lakartidningen. 2001 Apr 18;98(16):1905-10.
5
The economic value of individualizing drug therapy.个体化药物治疗的经济价值。
Manag Care Interface. 1997 Oct;10(10):96-8.
6
Cost of health care services in the treatment of cancer.癌症治疗中医疗服务的成本。
Aust Fam Physician. 1978 Aug;7(8):1062-74.
7
Pharmacoeconomics: determining the value of drug therapy.药物经济学：确定药物治疗的价值。
Healthplan. 1998 May-Jun;39(3):44-50.
8
Medication restrictions: feeling the side effects.药物限制：感受副作用。
Behav Healthc Tomorrow. 2001 Oct;10(5):14-7, 39-40.
9
Use of decision analysis to evaluate the costs and benefits of filgrastim (G-CSF) therapy.使用决策分析评估非格司亭（粒细胞集落刺激因子）治疗的成本和效益。
Formulary. 1995 Jul;30(7):394-5, 400-4.
10
News from "the real world": cost-effectiveness in palliative care.“真实世界”的消息：姑息治疗中的成本效益
Support Care Cancer. 1994 Jul;2(4):211-2.
Zotero 插件